UA81453C2 - Pyrazolopyridine derivates - Google Patents

Pyrazolopyridine derivates

Info

Publication number: UA81453C2
Authority: UA; Ukraine
Prior art keywords: pyrazolopyridine; derivates; compounds; prodrugs; solvates
Prior art date: 2003-02-27

Application number

UAA200507292A

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-27

Filing date

2004-02-27

Publication date

2008-01-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32930978&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA81453(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-02-27 Priority claimed from ES200300640A external-priority patent/ES2214150B1/es

2003-03-14 Priority claimed from ES200300727A external-priority patent/ES2214976B1/es

2004-02-27 Application filed filed Critical

2008-01-10 Publication of UA81453C2 publication Critical patent/UA81453C2/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Neurology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

UAA200507292A 2003-02-27 2004-02-27 Pyrazolopyridine derivates UA81453C2 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
ES200300640A ES2214150B1 (es)	2003-02-27	2003-02-27	"nuevos derivados de pirazolopiridinas".
ES200300727A ES2214976B1 (es)	2003-03-14	2003-03-14	"nuevos derivados de pirazolopiridinas".
ES200302504		2003-10-27
PCT/EP2004/001974 WO2004076450A1 (en)	2003-02-27	2004-02-27	Pyrazolopyridine derivates

Publications (1)

Publication Number	Publication Date
UA81453C2 true UA81453C2 (en)	2008-01-10

Family

ID=32930978

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAA200507292A UA81453C2 (en)	2003-02-27	2004-02-27	Pyrazolopyridine derivates

Country Status (29)

Country	Link
US (3)	US7468376B2 (pt)
EP (1)	EP1611131B1 (pt)
JP (1)	JP4814783B2 (pt)
KR (1)	KR101312736B1 (pt)
AR (1)	AR043416A1 (pt)
AT (1)	ATE481402T1 (pt)
AU (1)	AU2004215644B2 (pt)
BR (1)	BRPI0407811A (pt)
CA (1)	CA2515197C (pt)
CL (1)	CL2004000398A1 (pt)
CY (1)	CY1111544T1 (pt)
DE (1)	DE602004029145D1 (pt)
DK (1)	DK1611131T3 (pt)
EC (2)	ECSP056041A (pt)
HR (1)	HRP20050682B1 (pt)
IL (1)	IL196021A (pt)
IS (1)	IS2875B (pt)
MX (1)	MXPA05009069A (pt)
NO (1)	NO331917B1 (pt)
NZ (1)	NZ541836A (pt)
PE (1)	PE20050521A1 (pt)
PL (1)	PL378296A1 (pt)
PT (1)	PT1611131E (pt)
RS (1)	RS51768B (pt)
RU (1)	RU2359971C2 (pt)
SI (1)	SI1611131T1 (pt)
TW (1)	TWI325865B (pt)
UA (1)	UA81453C2 (pt)
WO (1)	WO2004076450A1 (pt)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004076450A1 (en) *	2003-02-27	2004-09-10	J. Uriach Y Compañia S.A.	Pyrazolopyridine derivates
ES2241496B1 (es) *	2004-04-15	2006-12-01	Almirall Prodesfarma, S.A.	Nuevos derivados de piridina.
TW200618800A (en) *	2004-08-03	2006-06-16	Uriach Y Compania S A J	Heterocyclic compounds
GB0427604D0 (en) *	2004-12-16	2005-01-19	Novartis Ag	Organic compounds
PE20061119A1 (es) *	2005-01-19	2006-11-27	Aventis Pharma Sa	PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie
FR2880891B1 (fr) *	2005-01-19	2007-02-23	Aventis Pharma Sa	Pyrazolo pyridines substituees, compositions les contenant, procede de fabrication et utilisation
JP2008546813A (ja) *	2005-06-27	2008-12-25	アンブリリアバイオファーマインコーポレーテッド	Ｈｉｖインテグラーゼ阻害剤としての［ピラゾロ［３，４−ｂ］ピリジン−２−イル］−安息香酸誘導体
CA2611296A1 (en) *	2005-06-27	2007-01-04	Sanofi-Aventis	Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1
ES2270715B1 (es)	2005-07-29	2008-04-01	Laboratorios Almirall S.A.	Nuevos derivados de pirazina.
FR2889526B1 (fr)	2005-08-04	2012-02-17	Aventis Pharma Sa	7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation
WO2007024680A1 (en)	2005-08-22	2007-03-01	Amgen Inc.	Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators
CN101242832B (zh)	2005-08-25	2011-08-10	霍夫曼-拉罗奇有限公司	用作p38 MAP激酶抑制剂的稠合吡唑
JP2009506006A (ja) *	2005-08-25	2009-02-12	エフ．ホフマン−ラロシュアーゲー	ｐ３８ＭＡＰキナーゼ阻害剤およびその使用方法
EP1924581A1 (en) *	2005-09-02	2008-05-28	Pfizer, Inc.	Hydroxy substituted 1h-imidazopyridines and methods
ES2274712B1 (es)	2005-10-06	2008-03-01	Laboratorios Almirall S.A.	Nuevos derivados imidazopiridina.
EP2514751A1 (en) *	2005-11-15	2012-10-24	Vertex Pharmaceuticals, Inc.	Azaindazoles useful as inhibitor of kinases
WO2008071456A2 (en) *	2006-12-15	2008-06-19	Bayer Schering Pharma Aktiengesellschaft	3-h-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
EP1932845A1 (en) *	2006-12-15	2008-06-18	Bayer Schering Pharma Aktiengesellschaft	3-H-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
WO2008104473A2 (en) *	2007-02-28	2008-09-04	F. Hoffmann-La Roche Ag	Pyrazolopyriidine derivatives and their use as kinase inhibitors
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
US8080546B2 (en)	2007-10-26	2011-12-20	Amgen Inc.	Pyrazolo-pyridinone derivatives and methods of use
EP2070929A1 (en)	2007-12-11	2009-06-17	Bayer Schering Pharma Aktiengesellschaft	Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
WO2009095752A1 (en) *	2008-01-29	2009-08-06	Glenmark Pharmaceuticals, S.A.	Fused pyrazole derivatives as cannabinoid receptor modulators
WO2010093595A1 (en)	2009-02-10	2010-08-19	E. I. Du Pont De Nemours And Company	Fungicidal 2-pyridones
WO2010111527A1 (en) *	2009-03-26	2010-09-30	Plexxikon, Inc.	Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
CN102595900B (zh)	2009-08-10	2015-07-15	萨穆梅德有限公司	Wnt信号传导途径的吲唑抑制剂及其治疗用途
WO2011019648A1 (en) *	2009-08-10	2011-02-17	Epitherix, Llc	Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof
EP2789614B1 (en)	2009-08-11	2017-04-26	Bristol-Myers Squibb Company	Azaindazoles as Btk kinase modulators and use thereof
FR2951172B1 (fr) *	2009-10-13	2014-09-26	Pf Medicament	Derives pyrazolopyridines en tant qu'agent anticancereux
PL3001903T3 (pl)	2009-12-21	2018-03-30	Samumed, Llc	1H-pirazolo[3,4-b]pirydyny i ich zastosowania terapeutyczne
WO2012009510A1 (en)	2010-07-15	2012-01-19	Bristol-Myers Squibb Company	Azaindazole compounds
CN102617548A (zh) *	2011-01-31	2012-08-01	北京赛林泰医药技术有限公司	作为gpr受体激动剂的双环杂芳基化合物及其组合物和应用
WO2012116151A2 (en) *	2011-02-24	2012-08-30	Cephalon, Inc.	Substituted aromatic sulfur compounds and methods of their use
SG10201914121YA (en)	2011-09-14	2020-03-30	Samumed Llc	Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
PH12017500997A1 (en)	2012-04-04	2018-02-19	Samumed Llc	Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
EP2770994B1 (en)	2012-05-04	2019-08-21	Samumed, LLC	1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
RU2495039C1 (ru) *	2012-07-31	2013-10-10	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный национальный исследовательский университет"	МЕТИЛ 3-МЕТИЛ-5-[2-(4-АРИЛАМИНО)-2-ОКСОАЦЕТИЛ]-1,6-ДИФЕНИЛ-1Н-ПИРАЗОЛО[3,4-b]ПИРИДИН-4-КАРБОКСИЛАТЫ И МЕТИЛ 3-МЕТИЛ-5-[2-(4-АРИЛАМИНО)-2-ОКСОАЦЕТИЛ]-6-СТИРИЛ-1-ФЕНИЛ-1Н-ПИРАЗОЛО[3,4-b]ПИРИДИН-4-КАРБОКСИЛАТЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ
CN105120862A (zh)	2013-01-08	2015-12-02	萨穆梅德有限公司	Wnt信号途径的3-(苯并咪唑-2-基)-吲唑抑制剂及其治疗应用
CN104230922B (zh) *	2013-06-19	2016-12-28	中国科学院上海药物研究所	一类五元杂环并吡啶类化合物及其制备方法和用途
PL3409674T3 (pl)	2013-10-17	2022-09-26	Blueprint Medicines Corporation	Sposób wytwarzania kompozycji użytecznych do leczenia zaburzeń związanych z KIT
WO2016040181A1 (en)	2014-09-08	2016-03-17	Samumed, Llc	3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
WO2016040193A1 (en)	2014-09-08	2016-03-17	Samumed, Llc	3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
WO2016040185A1 (en)	2014-09-08	2016-03-17	Samumed, Llc	2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
WO2016040182A1 (en)	2014-09-08	2016-03-17	Samumed, Llc	2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
WO2016040190A1 (en)	2014-09-08	2016-03-17	Samumed, Llc	3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
WO2016040180A1 (en)	2014-09-08	2016-03-17	Samumed, Llc	3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
WO2016040188A1 (en)	2014-09-08	2016-03-17	Samumed, Llc	3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
WO2016040184A1 (en)	2014-09-08	2016-03-17	Samumed, Llc	3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
US10226448B2 (en)	2015-08-03	2019-03-12	Samumed, Llc	3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
WO2017024025A1 (en)	2015-08-03	2017-02-09	Sunil Kumar Kc	3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
WO2017023980A1 (en)	2015-08-03	2017-02-09	Samumed, Llc.	3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
US10329309B2 (en)	2015-08-03	2019-06-25	Samumed, Llc	3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
US10350199B2 (en)	2015-08-03	2019-07-16	Samumed, Llc	3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
US10392383B2 (en)	2015-08-03	2019-08-27	Samumed, Llc	3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
WO2017023988A1 (en)	2015-08-03	2017-02-09	Samumed, Llc.	3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
US10463651B2 (en)	2015-08-03	2019-11-05	Samumed, Llc	3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
US10604512B2 (en)	2015-08-03	2020-03-31	Samumed, Llc	3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
US10206909B2 (en)	2015-08-03	2019-02-19	Samumed, Llc	3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
US10231956B2 (en)	2015-08-03	2019-03-19	Samumed, Llc	3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
US10285983B2 (en)	2015-08-03	2019-05-14	Samumed, Llc	3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof
US10206908B2 (en)	2015-08-03	2019-02-19	Samumed, Llc	3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
US10166218B2 (en)	2015-08-03	2019-01-01	Samumed, Llc	3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
US10383861B2 (en)	2015-08-03	2019-08-20	Sammumed, LLC	3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
US10226453B2 (en)	2015-08-03	2019-03-12	Samumed, Llc	3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
WO2017023972A1 (en)	2015-08-03	2017-02-09	Samumed, Llc.	3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
EP3370721A4 (en)	2015-11-06	2019-05-22	Samumed, LLC	TREATMENT OF OSTEOARTHRITIS
WO2017151409A1 (en)	2016-02-29	2017-09-08	University Of Florida Research Foundation, Incorporated	Chemotherapeutic methods
US20170275662A1 (en) *	2016-03-22	2017-09-28	The Quaker Oats Company	Method and Apparatus for Controlled Hydrolysis
AR108325A1 (es)	2016-04-27	2018-08-08	Samumed Llc	Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
EP3464285B1 (en)	2016-06-01	2022-09-21	BioSplice Therapeutics, Inc.	Process for preparing n-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide
GB201611712D0 (en)	2016-07-02	2016-08-17	Hvivo Services Ltd	Methods and compounds for the treatment or prevention of severe or persistent influenza
AU2017345699A1 (en)	2016-10-21	2019-05-16	Samumed, Llc	Methods of using indazole-3-carboxamides and their use as Wnt/B-catenin signaling pathway inhibitors
KR102558716B1 (ko)	2016-11-07	2023-07-21	사뮤메드, 엘엘씨	단일-투여량, 즉시-사용가능한 주사용 제제
US11040979B2 (en)	2017-03-31	2021-06-22	Blueprint Medicines Corporation	Substituted pyrrolo[1,2-b]pyridazines for treating disorders related to KIT and PDGFR
JOP20190278A1 (ar)	2017-05-31	2019-11-28	Novartis Ag	مركبات 5، 6-ثنائية الحلقة مندمجة وتركيبات لعلاج الأمراض الطفيلية
DK3691620T3 (da)	2017-10-05	2022-10-03	Fulcrum Therapeutics Inc	P38-kinaseinhibitor reducerer dux4- og downstream-gen-ekspression til behandling af fshd
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
GB201721793D0 (en) *	2017-12-22	2018-02-07	Hvivo Services Ltd	Methods and compunds for the treatment or prevention of hypercytokinemia and severe influenza
EP4302761A3 (en)	2019-04-12	2024-03-27	Blueprint Medicines Corporation	Crystalline forms of (s)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1h-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making
SMT202400229T1 (it)	2019-04-12	2024-07-09	Blueprint Medicines Corp	Derivati della pirrolotriazina per il trattamento delle malattie mediate da kit e pdgfra
WO2021067967A1 (en) *	2019-10-04	2021-04-08	University Of Kentucky Research Foundation	Preparation of pyrazolo[3,4-b]pyridines as antimalarials
EP4648772A1 (en)	2023-01-13	2025-11-19	Poolbeg Pharma (UK) Limited	Medicinal products and methods for the alleviation of cancer immunotherapy-associated cytokine release syndrome
WO2025093869A1 (en) *	2023-11-01	2025-05-08	Poolbeg Pharma (UK) Limited	P38 map kinase inhibitor for use in the treatment of inflammation

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3403158A (en)	1966-03-11	1968-09-24	Upjohn Co	1h-pyrazolo[3, 4-b]pyridines
US4264603A (en)	1980-03-17	1981-04-28	Sterling Drug Inc.	5-(Pyridinyl)-1H-pyrazolo[3,4-b]pyridine-3-amines, their use as cardiotonics and their preparation
US4361568A (en)	1981-04-28	1982-11-30	Sterling Drug Inc.	5-(Pyridinyl)-1H-pyrazolo[3,4-b]pyridin-3-amines and their cardiotonic use
US4375467A (en)	1981-09-28	1983-03-01	Sterling Drug Inc.	5-(Pyridinyl)-1H-pyrazolo[3,4-b] pyridines and their cardiotonic use
NZ266525A (en)	1993-07-06	1997-10-24	Pfizer	4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine derivatives and medicaments
JP3621706B2 (ja) *	1996-08-28	2005-02-16	ファイザー・インク	置換された６，５―ヘテロ―二環式誘導体
EP1043998B1 (en) *	1997-12-13	2007-03-07	Bristol-Myers Squibb Company	USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDANT KINASE INHIBITORS
US6559152B2 (en) *	1998-10-13	2003-05-06	Dupont Pharmaceuticals Company	6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
NZ511349A (en)	1998-11-03	2003-10-31	Glaxo Group Ltd	Pyrazolopyridine derivatives useful as selective COX-2 inhibitors
TWI265925B (en)	1999-10-11	2006-11-11	Pfizer	Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
ES2254238T3 (es)	1999-10-27	2006-06-16	Novartis Ag	Compuestos de tiazol e imidazo(4,5-b)piridina y su uso farmaceutico.
GB9929685D0 (en)	1999-12-15	2000-02-09	Merck Sharp & Dohme	Therapeutic agents
YU54202A (sh)	2000-01-18	2006-01-16	Agouron Pharmaceuticals Inc.	Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
JP2004507455A (ja) *	2000-04-25	2004-03-11	ブリストル−マイヤーズ　スクイブ　カンパニー	サイクリン依存性キナーゼ阻害剤としての、５−チオ−、スルフィニル−およびスルホニルピラゾロ［３，４−ｂ］−ピリジンの用途
BR0111377A (pt)	2000-06-06	2003-06-03	Pfizer Prod Inc	Derivados de tiofeno úteis como agentes anticancerìgenos
PE20020506A1 (es)	2000-08-22	2002-07-09	Glaxo Group Ltd	Derivados de pirazol fusionados como inhibidores de la proteina cinasa
EP1319001A1 (en)	2000-09-22	2003-06-18	Smithkline Beecham Plc	Pyrazolopyridines and pyrazolopyridazines as antidiabetics
AR031176A1 (es)	2000-11-22	2003-09-10	Bayer Ag	Nuevos derivados de pirazolpiridina sustituidos con piridina
JP2005501800A (ja) *	2001-02-02	2005-01-20	三菱ウェルファーマ株式会社	ジヒドロピラゾロピリジン化合物およびその医薬用途
ATE404568T1 (de)	2001-03-14	2008-08-15	Gruenenthal Gmbh	Substituierte thiazolopyrimidine als analgetika
GB0124848D0 (en) *	2001-10-16	2001-12-05	Celltech R&D Ltd	Chemical compounds
WO2003068773A1 (en) *	2002-02-12	2003-08-21	Glaxo Group Limited	Pyrazolopyridine derivatives
EP1545515A1 (en)	2002-08-12	2005-06-29	Sugen, Inc.	3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
UA81790C2 (uk)	2002-12-19	2008-02-11	Фармация Италия С.П.А.	Заміщені піролопіразольні похідні як інгібітори кінази
WO2004076450A1 (en) *	2003-02-27	2004-09-10	J. Uriach Y Compañia S.A.	Pyrazolopyridine derivates
EP1620095A4 (en)	2003-04-24	2009-04-01	Merck & Co Inc	HEMMER OF ACT ACTIVITY
AR044129A1 (es)	2003-05-06	2005-08-24	Altana Pharma Ag	Compuestos intermedios de imidazopiridina. proceso de preparacion.
AU2004274403A1 (en)	2003-09-03	2005-03-31	Aventis Pharmaceuticals Inc.	5-aryl-Pyrazolo(4,3-d)pyrimidines, pyridines, and pyrazines and related compounds

2004
- 2004-02-27 WO PCT/EP2004/001974 patent/WO2004076450A1/en not_active Ceased
- 2004-02-27 TW TW093105205A patent/TWI325865B/zh not_active IP Right Cessation
- 2004-02-27 AR ARP040100616A patent/AR043416A1/es not_active Application Discontinuation
- 2004-02-27 DE DE602004029145T patent/DE602004029145D1/de not_active Expired - Lifetime
- 2004-02-27 PE PE2004000211A patent/PE20050521A1/es not_active Application Discontinuation
- 2004-02-27 AU AU2004215644A patent/AU2004215644B2/en not_active Ceased
- 2004-02-27 PL PL378296A patent/PL378296A1/pl unknown
- 2004-02-27 KR KR1020057016025A patent/KR101312736B1/ko not_active Expired - Fee Related
- 2004-02-27 JP JP2006501971A patent/JP4814783B2/ja not_active Expired - Fee Related
- 2004-02-27 RS YU20050609A patent/RS51768B/sr unknown
- 2004-02-27 CA CA2515197A patent/CA2515197C/en not_active Expired - Fee Related
- 2004-02-27 NZ NZ541836A patent/NZ541836A/en not_active IP Right Cessation
- 2004-02-27 BR BRPI0407811-0A patent/BRPI0407811A/pt not_active IP Right Cessation
- 2004-02-27 RU RU2005130020/04A patent/RU2359971C2/ru active IP Right Revival
- 2004-02-27 UA UAA200507292A patent/UA81453C2/xx unknown
- 2004-02-27 EP EP04715268A patent/EP1611131B1/en not_active Expired - Lifetime
- 2004-02-27 AT AT04715268T patent/ATE481402T1/de active
- 2004-02-27 PT PT04715268T patent/PT1611131E/pt unknown
- 2004-02-27 CL CL200400398A patent/CL2004000398A1/es unknown
- 2004-02-27 US US10/547,232 patent/US7468376B2/en not_active Expired - Fee Related
- 2004-02-27 DK DK04715268.1T patent/DK1611131T3/da active
- 2004-02-27 SI SI200431568T patent/SI1611131T1/sl unknown
- 2004-02-27 HR HRP20050682AA patent/HRP20050682B1/hr not_active IP Right Cessation
- 2004-02-27 MX MXPA05009069A patent/MXPA05009069A/es active IP Right Grant
2005
- 2005-07-14 IS IS7939A patent/IS2875B/is unknown
- 2005-07-27 NO NO20053647A patent/NO331917B1/no not_active IP Right Cessation
- 2005-09-27 EC EC2005006041A patent/ECSP056041A/es unknown
2008
- 2008-09-08 US US12/206,289 patent/US8536194B2/en active Active
- 2008-12-18 IL IL196021A patent/IL196021A/en active IP Right Grant
2009
- 2009-07-29 US US12/511,469 patent/US20090286983A1/en not_active Abandoned
2010
- 2010-12-10 CY CY20101101149T patent/CY1111544T1/el unknown
2012
- 2012-03-30 EC ECSP12006041 patent/ECSP12006041A/es unknown

Also Published As

Publication number	Publication date
WO2004076450A8 (en)	2005-09-01
CL2004000398A1 (es)	2005-03-18
WO2004076450A1 (en)	2004-09-10
KR101312736B1 (ko)	2013-09-27
NO20053647D0 (no)	2005-07-27
MXPA05009069A (es)	2005-10-19
CA2515197C (en)	2011-10-18
AU2004215644A1 (en)	2004-09-10
EP1611131A1 (en)	2006-01-04
NZ541836A (en)	2008-12-24
JP2006519205A (ja)	2006-08-24
IS7939A (is)	2005-07-14
AR043416A1 (es)	2005-07-27
CY1111544T1 (el)	2015-08-05
SI1611131T1 (sl)	2011-03-31
HRP20050682B1 (hr)	2014-09-12
RU2359971C2 (ru)	2009-06-27
PT1611131E (pt)	2010-12-20
IL196021A (en)	2011-10-31
KR20060002782A (ko)	2006-01-09
BRPI0407811A (pt)	2006-02-14
TW200504061A (en)	2005-02-01
PL378296A1 (pl)	2006-03-20
NO20053647L (no)	2005-10-18
JP4814783B2 (ja)	2011-11-16
RU2005130020A (ru)	2006-07-10
HK1085214A1 (en)	2006-09-29
US7468376B2 (en)	2008-12-23
CA2515197A1 (en)	2004-09-10
ATE481402T1 (de)	2010-10-15
IL196021A0 (en)	2009-02-11
US20090286983A1 (en)	2009-11-19
RS51768B (sr)	2011-12-31
RS20050609A (sr)	2007-12-31
TWI325865B (en)	2010-06-11
US20060167040A1 (en)	2006-07-27
NO331917B1 (no)	2012-04-30
DE602004029145D1 (de)	2010-10-28
ECSP12006041A (es)	2012-12-28
US8536194B2 (en)	2013-09-17
US20090005377A1 (en)	2009-01-01
AU2004215644B2 (en)	2010-09-02
ECSP056041A (es)	2006-01-27
IS2875B (is)	2014-04-15
HRP20050682A2 (en)	2006-05-31
EP1611131B1 (en)	2010-09-15
DK1611131T3 (da)	2011-01-17
PE20050521A1 (es)	2005-09-11

Publication	Publication Date	Title
UA81453C2 (en)	2008-01-10	Pyrazolopyridine derivates
TW200618800A (en)	2006-06-16	Heterocyclic compounds
GEP20074236B (en)	2007-11-12	Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
PL372926A1 (en)	2005-08-08	Piperidine-pyridazones and phthalazones as pde4 inhibitors
TW200728277A (en)	2007-08-01	Bicyclic derivatives as P38 inhibitors
IL163781A0 (en)	2005-12-18	Purine derivatives as kinase inhibitors
MY132094A (en)	2007-09-28	Pyrrolo-triazine aniline compounds useful as kinase inhibitors
MX2009010595A (es)	2009-10-22	Derivados de pirrolopirimidina.
MX2009007302A (es)	2009-07-15	Derivados de purina.
NO20076345L (no)	2008-02-22	Bisykliske derivater som P38-kinaseinhibitorer
GB0308201D0 (en)	2003-05-14	Novel compounds
NO20082105L (no)	2008-07-31	Pyrazoloisokinolinderivater
MXPA05009151A (es)	2005-10-20	Inhibidores de cinasa heterociclica.
IS7507A (is)	2004-10-15	Ný efnasambönd
MX2008002104A (es)	2008-04-17	Derivados de 1-acildihidropirazol.
AP2002002466A0 (en)	2002-06-30	3-heterocycliylpropanohydroxamic acid PCP INHIBITORS.
IL173810A0 (en)	2006-07-05	Imidazopyridine derivatives and pharmaceutical compositions containing the same
MY145281A (en)	2012-01-13	Novel compounds
MY154498A (en)	2015-06-30	Pyrazolone derivatives as pde4 inhibitors
WO2007000337A8 (en)	2007-04-19	Bicyclic derivatives as p38 kinase inhibitors
MXPA05006957A (es)	2005-09-30	Nuevos derivados de fosforamida.
IL173895A0 (en)	2006-07-05	Imidazopyridine derivatives and pharmaceutical compositions containing the same
IS8034A (is)	2005-09-16	Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla
HK1139403A (en)	2010-09-17	Pyrrolopyrimidine derivatives as jak3 inhibitors